Renesas Electronics Corporation (RNECY)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	22,447	23,326	31,999	16,068	24,006	18,083
Market Cap Growth	-33.07%	-27.11%	99.15%	-33.07%	32.76%	53.34%
Enterprise Value	30,147	31,390	34,163	19,900	29,892	23,481
Last Close Price	6.00	6.33	8.94	4.39	6.20	5.23
PE Ratio	-	16.74	13.38	8.26	23.12	40.90
PS Ratio	2.55	2.72	3.07	1.41	2.78	2.61
PB Ratio	1.59	1.44	2.25	1.38	2.40	3.01
P/TBV Ratio	-	-	20.52	-	-	-
P/FCF Ratio	14.21	17.41	11.05	5.13	10.22	9.26
P/OCF Ratio	9.62	10.77	9.08	4.42	8.99	8.34
EV/Sales Ratio	3.51	3.66	3.28	1.75	3.46	3.39
EV/EBITDA Ratio	15.88	14.48	10.47	5.08	11.20	16.07
EV/EBIT Ratio	25.18	20.39	12.97	6.15	14.98	35.06
EV/FCF Ratio	19.09	23.43	11.79	6.35	12.73	12.02
Debt / Equity Ratio	0.66	0.56	0.33	0.50	0.72	1.12
Debt / EBITDA Ratio	4.79	4.10	1.44	1.48	2.67	4.45
Debt / FCF Ratio	5.92	6.76	1.64	1.86	3.07	3.44
Asset Turnover	0.34	0.35	0.49	0.57	0.49	0.44
Inventory Turnover	3.28	3.51	3.62	3.94	3.95	4.21
Quick Ratio	0.80	0.85	0.74	0.97	0.82	1.06
Current Ratio	1.18	1.26	0.97	1.36	1.16	1.40
Return on Equity (ROE)	-4.25%	9.65%	19.04%	19.09%	13.50%	7.35%
Return on Assets (ROA)	2.95%	3.95%	7.76%	10.18%	7.12%	2.64%
Return on Capital (ROIC)	3.44%	4.56%	9.32%	12.43%	8.71%	3.17%
Return on Capital Employed (ROCE)	5.30%	6.10%	15.90%	18.70%	11.60%	5.20%
Earnings Yield	-2.96%	5.97%	7.47%	12.11%	4.32%	2.44%
FCF Yield	7.04%	5.74%	9.05%	19.50%	9.79%	10.80%
Dividend Yield	2.93%	2.82%	2.22%	-	-	-
Payout Ratio	-	22.69%	-	-	-	-
Buyback Yield / Dilution	0.62%	-0.07%	4.81%	-0.86%	-7.40%	-3.71%
Total Shareholder Return	3.55%	2.75%	7.03%	-0.86%	-7.40%	-3.71%

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.